Format
Items per page
Sort by

Send to:

Choose Destination

Links from PubMed

Items: 12

1.

Promising cannabinoid-based therapies for Parkinson's disease: motor symptoms to neuroprotection.

More SV, Choi DK.

Mol Neurodegener. 2015 Apr 8;10:17. doi: 10.1186/s13024-015-0012-0. Review.

2.

WIN 55,212-2, agonist of cannabinoid receptors, prevents amyloid β1-42 effects on astrocytes in primary culture.

Aguirre-Rueda D, Guerra-Ojeda S, Aldasoro M, Iradi A, Obrador E, Mauricio MD, Vila JM, Marchio P, Valles SL.

PLoS One. 2015 Apr 13;10(4):e0122843. doi: 10.1371/journal.pone.0122843. eCollection 2015.

3.

The endocannabinoid system and sex steroid hormone-dependent cancers.

Ayakannu T, Taylor AH, Marczylo TH, Willets JM, Konje JC.

Int J Endocrinol. 2013;2013:259676. doi: 10.1155/2013/259676. Epub 2013 Nov 27. Review.

4.

Opposite function of dopamine D1 and N-methyl-D-aspartate receptors in striatal cannabinoid-mediated signaling.

Daigle TL, Wetsel WC, Caron MG.

Eur J Neurosci. 2011 Nov;34(9):1378-89. doi: 10.1111/j.1460-9568.2011.07874.x.

5.

Cannabinoid receptor expression in HIV encephalitis and HIV-associated neuropathologic comorbidities.

Cosenza-Nashat MA, Bauman A, Zhao ML, Morgello S, Suh HS, Lee SC.

Neuropathol Appl Neurobiol. 2011 Aug;37(5):464-83. doi: 10.1111/j.1365-2990.2011.01177.x.

6.

The dual neuroprotective-neurotoxic profile of cannabinoid drugs.

Sarne Y, Asaf F, Fishbein M, Gafni M, Keren O.

Br J Pharmacol. 2011 Aug;163(7):1391-401. doi: 10.1111/j.1476-5381.2011.01280.x. Review.

7.

Endocannabinoids and immune regulation.

Pandey R, Mousawy K, Nagarkatti M, Nagarkatti P.

Pharmacol Res. 2009 Aug;60(2):85-92. doi: 10.1016/j.phrs.2009.03.019. Epub 2009 Apr 7. Review.

8.
9.

The endocannabinoid system as an emerging target of pharmacotherapy.

Pacher P, Bátkai S, Kunos G.

Pharmacol Rev. 2006 Sep;58(3):389-462. Review.

10.

A pilot clinical study of Delta9-tetrahydrocannabinol in patients with recurrent glioblastoma multiforme.

Guzmán M, Duarte MJ, Blázquez C, Ravina J, Rosa MC, Galve-Roperh I, Sánchez C, Velasco G, González-Feria L.

Br J Cancer. 2006 Jul 17;95(2):197-203. Epub 2006 Jun 27.

11.

Ceramide sensitizes astrocytes to oxidative stress: protective role of cannabinoids.

Carracedo A, Geelen MJ, Diez M, Hanada K, Guzmán M, Velasco G.

Biochem J. 2004 Jun 1;380(Pt 2):435-40.

12.

Anandamide and vanilloid TRPV1 receptors.

Ross RA.

Br J Pharmacol. 2003 Nov;140(5):790-801. Epub 2003 Sep 29. Review.

Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk